8.93 USD
↘ 0.71 (7.37%)AT CLOSE (11:59 AM EDT)
Cartesian Therapeutics, Inc. Common Stock
RNACNASDAQ • USD
9.36
↗ 0.43 (4.83%)
POST MARKET (AS OF 04:53 PM EDT)
Post Market
AS OF 04:53 PM EDT
9.36
↗ 0.43 (4.83%)
Market: OPEN
Cartesian Therapeutics, Inc. Common Stock (RNAC) trades at $9.36 per share. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (104.2%) and a bearish Death Cross on the long-term moving averages. On the valuation front, RNAC trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Jun 25, 2026.
Open?$9.56
High?$9.60
Low?$8.85
Prev. Close?$9.64
Volume?265.8K
Avg. Volume?364.1K
VWAP?$9.17
Rel. Volume?0.73x
Bid / Ask
Bid?$7.55 × 100
Ask?$10.26 × 100
Spread?$2.71
Midpoint?$8.91
Valuation & Ratios
Market Cap?283.2M
Shares Out?29.4M
Float?12.1M
Float %?41.0%
P/E Ratio?N/A
P/B Ratio?-1.91
EPS?-$5.26
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Themes
Employees
75
Market Cap
283.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-06-22
Address
7495 NEW HORIZON WAY
FREDERICK, MD 21703
Phone: 301-348-8698
FREDERICK, MD 21703
Phone: 301-348-8698
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?19
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.04Distress
Confidence?73%Moderate
Short InterestVery High
Short % of Float?19.01%High
Short Interest?2.3M
Days to Cover?12.4
Free Float12.1M
Avg Daily Volume185.3K
Settlement Date2026-05-29
Financial Health
Current Ratio?7.65Strong
Quick Ratio?7.65Strong
Cash Ratio?7.44Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-1.91CHEAP▾
S&P97
P/S?159.57HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.9CHEAP▾
S&P97
EV/Sales?92.73HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?104.2%STRONG▾
Peers50
S&P97
ROA?-53.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-77374000
Enterprise Value?$164.6M
Fundamentals ratios updated end of day